Staidson (beijing) Biopharmaceuticals Co., Ltd

This study tests an experimental drug called STSA-1002 in 406 adults with acute respiratory distress syndrome (ARDS), a severe lung condition often caused by viral infections. The goal is to see if the drug reduces the chance of death within 28 days and helps patients recover fas…

This study tests whether adding BDB-001 to standard treatments (cyclophosphamide/azathioprine or rituximab) helps more people with ANCA vasculitis reach remission. About 300 adults with active GPA or MPA will receive either BDB-001 or a placebo. The goal is to reduce disease acti…

This study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a rare eye disease where the cornea loses feeling and can develop sores or ulcers. About 48 adults with moderate to severe disease will receive either the drug or a placebo for 8 we…

This study tests a new drug called STSP-0902 in healthy men and men with low sperm count. The main goal is to see if the drug is safe and how the body handles it. Researchers will give either the drug or a placebo and watch for side effects. This is an early-stage trial, so it fo…